GRAIL, Inc. - Common Stock (GRAL)

GRAIL, Inc. is a biotechnology company focused on the early detection of cancer through innovative blood tests

The company is dedicated to advancing its proprietary multi-cancer early detection technology, which aims to identify various types of cancer in their earliest, most treatable stages. By utilizing advanced genomic science and machine learning techniques, GRAIL seeks to improve patient outcomes and transform the landscape of cancer diagnostics, ultimately contributing to earlier interventions and better survival rates.